AIM
DGX icon

Alambic Investment Management’s Quest Diagnostics DGX Stock Holding History

Alambic Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,515
Closed -$247K – 592
2017
Q1 		$247K Sell
2,515
-735
-23% -$70.1K 0.03% 542
2016
Q4 		$299K Sell
3,250
-1,500
-32% -$129K 0.05% 425
2016
Q3 		$402K Hold
4,750
– – 0.09% 323
2016
Q2 		$387K Sell
4,750
-80
-2% -$6.09K 0.1% 332
2016
Q1 		$345K Buy
4,830
+1,400
+41% +$93.9K 0.11% 289
2015
Q4 		$244K Buy
+3,430
New +$231K 0.15% 256

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alambic Investment Management's DGX Position: Q2 2017 in Review

Alambic Investment Management sold out of Quest Diagnostics (DGX) in Q2 2017, closing a stake of 2,515 shares — an estimated $247K sold.

Alambic Investment Management first reported a position in DGX in Q4 2015 and held it in 6 quarters. The position peaked at $402K in Q3 2016. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.

  • Alambic Investment Management reported no remaining Quest Diagnostics position as of Q2 2017 after selling out during the quarter.
  • Alambic Investment Management sold 2,515 Quest Diagnostics shares in Q2 2017, an estimated $247K.
  • Alambic Investment Management first reported a position in Quest Diagnostics in Q4 2015 and held it in 6 quarters.
  • Alambic Investment Management's Quest Diagnostics position peaked at $402K in Q3 2016.
  • 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.

Based on Alambic Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.